EpiFix® Amniotic Membrane Allograft

DMCA.com Protection Status

EpiFix® Amniotic Membrane Allograft is intended for homologous use in the treatment of acute and chronic partial- and full-thickness wounds for the reduction of scar tissue formation, modulation of inflammation, and enhancement of healing.

Product Video
Product Literature

MiMedx Group, Inc. develops, processes, manufactures and markets patented biomaterial products and tissues including EpiFix® Amniotic Membrane Allograft for acute and chronic wounds.

(770) 651-9100
(866) 477-4219
(770) 590-3550

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.